Breakthrough research reveals a new target for Alzheimer’s disease treatment http://t.co/PxlDwZHw8U pic.twitter.com/bORU66m2qd — PsyPost.org (@PsyPost) October 15, 2015 A research team led by Amantha Thathiah (VIB/KU Leuven) has determined that a protein – known as GPR3 – might play an important role in alleviating the cognitive deficits and reducing theContinue Reading

https://health.clevelandclinic.org/2015/10/peanut-butter-test-may-detect-alzheimers/?utm_campaign=cc%20posts&utm_medium=social&utm_source=twitter&utm_content=210118%20alzh&cvosrc=social%20network.twitter.cc%20posts&cvo_creative=200118%20alzh Here’s how they conducted the test. The researchers asked each person to close their eyes, their mouth and one nostril. They opened a small container of peanut butter and moved progressively closer until the person could smell it. After measuring that distance, they waited 90 seconds and repeated the processContinue Reading

Breakthrough research reveals a new target for Alzheimer’s disease treatment http://t.co/PxlDwZHw8U pic.twitter.com/bORU66m2qd — PsyPost.org (@PsyPost) October 15, 2015 A research team led by Amantha Thathiah (VIB/KU Leuven) has determined that a protein – known as GPR3 – might play an important role in alleviating the cognitive deficits and reducing theContinue Reading

Paul Aisen, M.DA leading researcher in Alzheimer’s disease clinical trials, Paul Aisen, M.D., has joined the faculty of the University of California, San Diego (UCSD) School of Medicine’s Department of Neurosciences. He has also been named director of the Alzheimer’s Disease Cooperative Study (ADCS), a position he has held onContinue Reading